Question 1

What is Ixazomib?

Accepted Answer

Ixazomib is a type of medication known as a proteasome inhibitor. It works by interfering with the function of proteasomes, which are protein complexes found within cells that help break down other proteins.

By blocking these complexes, the medication can disrupt the normal processes of cancer cells. This action helps to stop the growth and spread of cancer cells throughout the body.

Question 2

What is Ixazomib used for?

Accepted Answer

Ixazomib is used to treat multiple myeloma.

Question 3

How does Ixazomib work?

Accepted Answer

Mechanism of Action

Ixazomib belongs to a class of medications called proteasome inhibitors. It works by targeting and blocking the activity of proteasomes, which are enzyme complexes found within cells.

Proteasomes function as a waste disposal system for cells, breaking down and recycling proteins that are damaged or no longer needed. Cancer cells, particularly multiple myeloma cells, produce proteins at a high rate and depend on proteasomes to keep the cell functioning properly.

When ixazomib blocks these proteasomes, the following occurs:

Protein Buildup: Unwanted proteins begin to accumulate inside the cancer cell because they cannot be broken down.

Cellular Stress: The buildup of these proteins creates a toxic environment and causes significant stress to the cell structure.

Cell Death: This internal stress eventually triggers the cancer cell to stop dividing and undergo a process of programmed cell death.

Because cancer cells are often more dependent on proteasome activity than healthy cells, they are more sensitive to the effects of this medication. This allows the drug to help slow or stop the progression of the cancer while minimizing the impact on normal cells.

Question 4

What are the brand names for Ixazomib?

Accepted Answer

Ixazomib is sold under the brand name Ninlaro .

Question 5

What are the active ingredients in Ixazomib?

Accepted Answer

The active ingredient in Ixazomib is ixazomib .

Question 6

What are the side effects of Ixazomib?

Accepted Answer

Common side effects of Ixazomib may include:

diarrhea

nausea

vomiting

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Ixazomib?

Accepted Answer

Ixazomib belongs to the proteasome inhibitor drug class.

Question 8

What is the dosage of Ixazomib and how do I take it?

Accepted Answer

How to Take Ixazomib

Ixazomib is typically taken once a week on the same day each week for the first three weeks of a four-week treatment cycle. It should be taken on an empty stomach, at least one hour before or at least two hours after eating.

The capsule must be swallowed whole with water. Do not crush, chew, or open the capsule. If a capsule is accidentally broken or leaks, avoid getting the powder on your skin or in your eyes. If contact occurs, wash the skin thoroughly with soap and water or flush the eyes with plenty of water.

Missed Doses and Vomiting

If you miss a dose, take it as soon as you remember, provided that your next scheduled dose is not due for at least 72 hours. If the next dose is less than 72 hours away, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

If you vomit after taking a dose, do not take an additional dose. Wait and take your next dose at the regularly scheduled time.

Question 9

Is Ixazomib safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Ixazomib may cause fetal harm when administered to a pregnant woman. Animal studies have indicated that the drug can cause structural abnormalities and fetal death. Because of these risks, healthcare providers typically perform a pregnancy test before starting treatment to ensure a patient is not pregnant.

Patients of reproductive potential should use effective contraception according to the following guidelines:

Females: Use effective birth control during treatment and for at least 90 days after the final dose.

Males: Use effective birth control (such as condoms) during treatment and for at least 90 days after the final dose if their partner is pregnant or could become pregnant.

If a patient becomes pregnant while taking this medication, they should contact their healthcare provider immediately to discuss the potential risks to the fetus.

Breastfeeding

It is not known whether ixazomib passes into human breast milk. Because many drugs are excreted in human milk and there is a potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment. Patients should avoid breastfeeding while taking ixazomib and for at least 90 days after the last dose.

Question 10

What forms and strengths does Ixazomib come in?

Accepted Answer

Available Forms

Ixazomib is supplied as a capsule for oral administration. The capsules are color-coded to help distinguish between the different strengths available.

The medication is typically provided in blister packaging. It is important to keep the capsules in their original container until the time of use and to avoid breaking or opening the capsules.

Question 11

What is the FDA approval status of Ixazomib?

Accepted Answer

FDA Approval and Indications

Ixazomib was approved by the U.S. Food and Drug Administration (FDA) in November 2015. It is indicated for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Safety and Monitoring

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) programs required for ixazomib. However, the FDA monitors the safety of the drug through the FDA Adverse Event Reporting System (FAERS). In 2018, the FDA identified potential signals of serious skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, which led to updates in the product labeling to include these risks.

Healthcare providers are advised to monitor patients for signs of severe skin reactions, liver toxicity, and low platelet counts while they are taking this medication.

Question 12

What should I know about Ixazomib and cost?

Accepted Answer

Insurance and Prior Authorization

Ixazomib is a specialty medication used for the treatment of multiple myeloma. Most private insurance plans and Medicare Part D provide coverage for this drug, but out-of-pocket costs can vary. Insurance companies often require prior authorization, a process where the healthcare provider must justify the medical necessity of the drug before the insurer agrees to cover the cost.

Specialty Pharmacy Requirements

Because ixazomib requires special handling and monitoring, it is typically dispensed through specialty pharmacies rather than standard retail pharmacies. These specialty pharmacies often coordinate with insurance providers and may offer services to help patients manage the high cost of the medication.

Financial Assistance Programs

For patients who face high out-of-pocket expenses or lack insurance coverage, financial assistance may be available. Many manufacturers offer patient assistance programs or copay cards to reduce the cost for eligible individuals. Additionally, independent non-profit foundations may provide grants to help cover the costs of cancer treatments for those who meet specific financial criteria.

Generic Availability

Ixazomib is currently available as a brand-name medication. Generic versions are not yet widely available, which generally results in a higher cost compared to medications that have generic alternatives.

Ixazomib

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?